Trials / Completed
CompletedNCT05807633
Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section
Assessment on the Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section. A Retrospective, Monocenter, Observational Study in Daily Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- Aesculap AG · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to collect clinical data on the use of Novosyn® applied for the uterus closure in cesarean section. Diverse parameters have been selected to assess that the safety and effectiveness of Novosyn® is comparable to published results, where the rate of SSIs in patients undergoing uterus closure in cesarean section was 10.6%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Novosyn® | Novosyn® for uterus closure in patients undergoing cesarian section |
Timeline
- Start date
- 2022-06-15
- Primary completion
- 2023-03-28
- Completion
- 2023-10-01
- First posted
- 2023-04-11
- Last updated
- 2023-10-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05807633. Inclusion in this directory is not an endorsement.